Company: LRHC
Filing Date: 2025-08-22
Form Type: 424B3
Source: 0001213900-25-079984
Chunk: 9

Company: La Rosa Holdings Corp.
Filing Date: 2025-08-22
Form: 424B3
Chunk 9
---
. The Company also granted 2025 Investor registration rights in the shares of common stock issuable pursuant to the SPA and conversion
of the Notes. The Company Group also entered into a security agreement with 2025 Investor pursuant to which the Company Group granted
the 2025 Investor a security interest in certain property of the Company Group to secure the Company’s obligations under the Notes.
The Company also agreed to obtain stockholder approval for the issuance of more than 19.99% of the issued and outstanding common stock
in this financing.

<div align='center'>2</div>

On February 4, 2025, as required by the SPA, stockholders holding a
majority of the voting power of the Company, approved (i) the issuance of the Initial Note, the Incremental Warrants and Incremental Notes,
all Interest Shares and all of the Conversion Shares and Incremental Conversion Shares in excess of 19.99% (without regard to any limitation
on conversion or exercise thereof) of the Company’s issued and outstanding common stock at a price less than the minimum price required
by the Nasdaq in accordance with Nasdaq Listing Rules 5635(b) and 5635(d); (ii) authorization to complete a reverse split of our common
stock; and (iii) authorization to increase the number of authorized shares of our common stock to ensure that the Company has a sufficient
number of authorized shares reserved for issuance to equal at least 200% of the maximum number of shares issuable upon conversion of the
Notes, as determined under the Securities Purchase Agreement. Such approval was effective on March 27, 2025, or 20 days after commencement
of mailing of the definitive information statement regarding this approval to the stockholders of the Company.

On June 18, 2025, with the prior approval by the
Company’s Board of Directors, the Company and the 2025 Investor entered into, and closed the transactions contemplated by, that
certain Amendment and Exchange Agreement (the “Exchange Agreement”) pursuant to which (among other things) the 2025 Investor
surrendered and exchanged all of its Incremental Warrants in exchange for (the “Exchange”) 6,000 shares of the Company’s
Series B Convertible Preferred Stock, par value $0.0001 per share (“Series B Preferred Stock”). On the same date, the Company
filed a Certificate of Designation of Rights and Preferences of the Series B Preferred Stock (the “Certificate of Design